TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06519032: Development and Evaluation of Rapid Bacterial Species Identification for Acid-Fast Bacilli Smear Using Image Analysis AI

Sponsor: GramEye · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 10000 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$9,408,000

Rescue Site Savings

+$6,203,400

Unlock Full NCT06519032 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06519032 Rescue Dossier →